Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size Growth Rate by Type (2019-2025)
1.3.2 ESRD
1.3.3 Cancer
1.3.4 HIV
1.3.5 Wounds and neural disease
1.4 Market Segment by Application
1.4.1 Global Recombinant Human Erythropoietin (rhEPO) Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Retail Pharmacies
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Recombinant Human Erythropoietin (rhEPO) Production Value 2014-2025
2.1.2 Global Recombinant Human Erythropoietin (rhEPO) Production 2014-2025
2.1.3 Global Recombinant Human Erythropoietin (rhEPO) Capacity 2014-2025
2.1.4 Global Recombinant Human Erythropoietin (rhEPO) Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size CAGR of Key Regions
2.2.2 Global Recombinant Human Erythropoietin (rhEPO) Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Recombinant Human Erythropoietin (rhEPO) Capacity by Manufacturers
3.1.2 Global Recombinant Human Erythropoietin (rhEPO) Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Recombinant Human Erythropoietin (rhEPO) Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Human Erythropoietin (rhEPO) Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Recombinant Human Erythropoietin (rhEPO) Market Concentration Ratio (CR5 and HHI)
3.3 Recombinant Human Erythropoietin (rhEPO) Price by Manufacturers
3.4 Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Recombinant Human Erythropoietin (rhEPO) Market
3.6 Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 ESRD Production and Production Value (2014-2019)
4.1.2 Cancer Production and Production Value (2014-2019)
4.1.3 HIV Production and Production Value (2014-2019)
4.1.4 Wounds and neural disease Production and Production Value (2014-2019)
4.2 Global Recombinant Human Erythropoietin (rhEPO) Production Market Share by Type
4.3 Global Recombinant Human Erythropoietin (rhEPO) Production Value Market Share by Type
4.4 Recombinant Human Erythropoietin (rhEPO) Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption by Application

6 Production by Regions
6.1 Global Recombinant Human Erythropoietin (rhEPO) Production (History Data) by Regions 2014-2019
6.2 Global Recombinant Human Erythropoietin (rhEPO) Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Recombinant Human Erythropoietin (rhEPO) Production Growth Rate 2014-2019
6.3.2 United States Recombinant Human Erythropoietin (rhEPO) Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Recombinant Human Erythropoietin (rhEPO) Import & Export
6.4 European Union
6.4.1 European Union Recombinant Human Erythropoietin (rhEPO) Production Growth Rate 2014-2019
6.4.2 European Union Recombinant Human Erythropoietin (rhEPO) Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Recombinant Human Erythropoietin (rhEPO) Import & Export
6.5 China
6.5.1 China Recombinant Human Erythropoietin (rhEPO) Production Growth Rate 2014-2019
6.5.2 China Recombinant Human Erythropoietin (rhEPO) Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Recombinant Human Erythropoietin (rhEPO) Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia

7 Recombinant Human Erythropoietin (rhEPO) Consumption by Regions
7.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Recombinant Human Erythropoietin (rhEPO) Consumption by Type
7.2.2 United States Recombinant Human Erythropoietin (rhEPO) Consumption by Application
7.3 European Union
7.3.1 European Union Recombinant Human Erythropoietin (rhEPO) Consumption by Type
7.3.2 European Union Recombinant Human Erythropoietin (rhEPO) Consumption by Application
7.4 China
7.4.1 China Recombinant Human Erythropoietin (rhEPO) Consumption by Type
7.4.2 China Recombinant Human Erythropoietin (rhEPO) Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Recombinant Human Erythropoietin (rhEPO) Consumption by Type
7.5.2 Rest of World Recombinant Human Erythropoietin (rhEPO) Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia

8 Company Profiles
8.1 3SBio
8.1.1 3SBio Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.1.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.1.5 3SBio Recent Development
8.2 Shanghai Chemo
8.2.1 Shanghai Chemo Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.2.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.2.5 Shanghai Chemo Recent Development
8.3 Chengdu Diao
8.3.1 Chengdu Diao Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.3.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.3.5 Chengdu Diao Recent Development
8.4 NCPC Genetech
8.4.1 NCPC Genetech Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.4.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.4.5 NCPC Genetech Recent Development
8.5 Kyowa Hakko Kirin
8.5.1 Kyowa Hakko Kirin Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.5.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.5.5 Kyowa Hakko Kirin Recent Development
8.6 Shandong Kexing
8.6.1 Shandong Kexing Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.6.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.6.5 Shandong Kexing Recent Development
8.7 Ahua Pharmaceutical
8.7.1 Ahua Pharmaceutical Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.7.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.7.5 Ahua Pharmaceutical Recent Development
8.8 Biosidus
8.8.1 Biosidus Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.8.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.8.5 Biosidus Recent Development
8.9 Dragon Pharma
8.9.1 Dragon Pharma Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Recombinant Human Erythropoietin (rhEPO)
8.9.4 Recombinant Human Erythropoietin (rhEPO) Product Introduction
8.9.5 Dragon Pharma Recent Development

9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Recombinant Human Erythropoietin (rhEPO) Capacity, Production Forecast 2019-2025
9.1.2 Global Recombinant Human Erythropoietin (rhEPO) Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Recombinant Human Erythropoietin (rhEPO) Production and Value Forecast by Regions 2019-2025
9.2.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Recombinant Human Erythropoietin (rhEPO) Production Forecast by Type
9.7.2 Global Recombinant Human Erythropoietin (rhEPO) Production Value Forecast by Type
9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Recombinant Human Erythropoietin (rhEPO) Sales Channels
10.2.2 Recombinant Human Erythropoietin (rhEPO) Distributors
10.3 Recombinant Human Erythropoietin (rhEPO) Customers

11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis

12 Key Findings

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer